Patents by Inventor Xuyu CHAI

Xuyu CHAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS, METHOD OF MAKING AND METHOD OF USING THEREOF
    Publication number: 20230364114
    Abstract: Pharmaceutical compositions suitable for long-term storage at room temperature are described. The pharmaceutical composition comprises the compound of formula (I) and can be used for the treatment of steatohepatitis. Also described are methods for preparing the pharmaceutical composition and methods of treatment using the pharmaceutical compositions.
    Type: Application
    Filed: July 24, 2023
    Publication date: November 16, 2023
    Inventors: Jinzi Jason WU, Xuyu CHAI
  • Pharmaceutical compositions, method of making and method of using thereof
    Patent number: 11752161
    Abstract: Pharmaceutical compositions suitable for long-term storage at room temperature are described. The pharmaceutical composition comprises the compound of formula (1) and can be used for the treatment of steatohepatitis. Also described are methods for preparing the pharmaceutical composition and methods of treatment using the pharmaceutical compositions.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: September 12, 2023
    Assignee: GANNEX PHARMA CO., LTD.
    Inventors: Jinzi Jason Wu, Xuyu Chai
  • Pharmaceutical compositions comprising a thyroid hormone beta agonist, method of use and method making thereof
    Patent number: 11583502
    Abstract: A pharmaceutical formulation contains the following components in part by weight: (a) 1 part of the compound represented by Formula (I), (b) 16 to 600 parts of a meltable and dispersible carrier comprising poloxamer and polyethylene glycol in a poloxamer-to-polyethylene glycol weight ratio of 1-0.5 to 1:27, and (c) 0.2 to 100 parts of a non-volatile weak acid. The pharmaceutical formulation helps to improve the in vitro dissolution of the compound of Formula (I).
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: February 21, 2023
    Assignee: GANNEX PHARMA CO., LTD.
    Inventors: Jinzi Jason Wu, Xuyu Chai
  • PHARMACEUTICAL COMPOSITIONS, METHOD OF MAKING AND METHOD OF USING THEREOF
    Publication number: 20210308155
    Abstract: Pharmaceutical compositions suitable for long-term storage at room temperature are described. The pharmaceutical composition comprises the compound of formula (I) and can be used for the treatment of steatohepatitis. Also described are methods for preparing the pharmaceutical composition and methods of treatment using the pharmaceutical compositions.
    Type: Application
    Filed: March 25, 2021
    Publication date: October 7, 2021
    Inventors: Jinzin Jason WU, Xuyu CHAI
  • PHARMACEUTICAL COMPOSITIONS COMPRISING A THYROID HORMONE BETA AGONIST, METHOD OF USE AND METHOD MAKING THEREOF
    Publication number: 20210259977
    Abstract: A pharmaceutical formulation contains the following components in part by weight: (a) 1 part of the compound represented by Formula (I), (b) 16 to 600 parts of a meltable and dispersible carrier comprising poloxamer and polyethylene glycol in a poloxamer-to-polyethylene glycol weight ratio of 1-0.5 to 1:27, and (c) 0.2 to 100 parts of a non-volatile weak acid. The pharmaceutical formulation helps to improve the in vitro dissolution of the compound of Formula (I).
    Type: Application
    Filed: April 16, 2021
    Publication date: August 26, 2021
    Inventors: Jinzi Jason WU, Xuyu CHAI